A Nonsynonymous Mutation in PLCG2 Reduces the Risk of Alzheimer's Disease, Dementia with Lewy-Bodies and Frontotemporal Dementia, and Increases the Likelihood of Longevity
Sven J. van der Lee(Amsterdam Neuroscience), Heinz Wiendl(University Medical Center Freiburg), Marc Hulsman(Amsterdam University Medical Centers), Juan Fortea(Hospital de Sant Pau), Manuel A. Friese(Universität Hamburg), Jonas Mengel‐From(University of Southern Denmark), Kaj Blennow(Sahlgrenska University Hospital), Erik B. van den Akker(Leiden University Medical Center), Itziar de Rojas(Instituto de Salud Carlos III), Bernard Jeune(University of Southern Denmark), Jeanne E. Savage(Amsterdam Neuroscience), Michael J. Keogh(University of Cambridge), Najada Stringa(Amsterdam University Medical Centers), Luca Kleineidam(University of Bonn), Michael Wagner(University of Bonn), Iris E. Jansen(Amsterdam Neuroscience), Anna Zettergren(University of Gothenburg), Bart N.M. van Berckel(Amsterdam Neuroscience), Martin Scherer(Universität Hamburg), Marianne Nygaard(University of Southern Denmark), Ingmar Skoog(Sahlgrenska University Hospital), Carmen Lage(University of Oxford), Steffi G. Riedel‐Heller(Leipzig University), Cornelis Blauwendraat(National Institute of Neurological Disorders and Stroke), Till F. M. Andlauer(TUM Klinikum), Florian Then Bergh(Leipzig University), Adela Orellana(Universitat Internacional de Catalunya), Christopher M. Morris(NIHR Newcastle Biomedical Research Centre), Henrik Zetterberg(University of Wisconsin–Madison), Javier Simón‐Sánchez(Amsterdam UMC Location Vrije Universiteit Amsterdam), Miren Zulaica(Biomedical Research Networking Center on Neurodegenerative Diseases), Mónica Díez-Fairén(University Hospital Mútua de Terrassa), Nina Beker(Amsterdam Neuroscience), Daniel Alcolea(Hospital de Sant Pau), Sonia Moreno–Grau(Galena Biopharma (United States)), Wei Wei(University of Cambridge), Xue Wang(Third Affiliated Hospital of Southern Medical University), Olga Pletnikova(Johns Hopkins University), Jason Chen(University of California, Los Angeles), Kristel R. van Eijk(Utrecht University), Minerva M. Carrasquillo(Jacksonville College), Lyduine E. Collij(Lund University), Olivia J. Conway(Leiden University Medical Center), James W. Ironside(MRC Centre for Regenerative Medicine)
Cited by 26
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
|Nature Genetics|2019|3.3k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k